comparemela.com

Page 4 - Pac Clinical Trials News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Novotech Acquires European CRO – Strengthens Global

SINGAPORE, Jan. 12, 2023 (GLOBE NEWSWIRE) Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and regulatory.

United statesJohn mollerAsia pacificNorth americaPac clinical trialsClinical trialsDrug development

Data Shows 50% of New Trials Have Sites in Asia Pacific

SINGAPORE, Dec. 14, 2022 (GLOBE NEWSWIRE) Novotech, the Asia Pacific centered biotech specialist CRO said the latest industry research publication by.

United statesAsia pacific novotechSullivan asia pacificAsia pacificJohn mollerDavid jamesCompany of the year awardFrost sullivan company of the year awardSite partnershipGlobal biotech landscapeOpportunities lieSullivan companyYear awardBest practicesSullivan asia pacific best practicesCell therapy excellence

Novotech Awarded the Asia Pacific CRO of the Year 2022 for

SINGAPORE, Dec. 05, 2022 (GLOBE NEWSWIRE) Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Frost & Sullivan Company.

United statesAsia pacific novotechSullivan asia pacificAsia pacificJohn mollerDavid jamesCompany of the year awardFrost sullivan company of the year awardSite partnershipSullivan companyYear awardBest practicesSullivan asia pacific best practicesCell therapy excellencePac clinical trialsSia pacific drug development

Clinical Research Opportunities in China and the Path to

SYDNEY, Australia, Oct. 30, 2022 (GLOBE NEWSWIRE) Novotech, the leading Asia Pacific biotech specialist CRO, and GlobalData have published the latest.

New south walesYooni kimAsia pacific novotechAsia pacificGlobal head of clinical services drSite partnershipVice presidentGlobal headClinical servicesMarketing authorization holderCell therapy excellenceClinical trialsDrug developmentPac clinical trialsHina clinical trials

vimarsana © 2020. All Rights Reserved.